• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧反应中 SUMO-1 表达增加:与低氧性肺动脉高压中的 HIF-1α 相互作用。

Increased SUMO-1 expression in response to hypoxia: Interaction with HIF-1α in hypoxic pulmonary hypertension.

机构信息

Institute of Respiratory Medicine, Hunan Province Geriatric Hospital, Changsha, Hunan 410016, P.R. China.

出版信息

Int J Mol Med. 2015 Jul;36(1):271-81. doi: 10.3892/ijmm.2015.2209. Epub 2015 May 14.

DOI:10.3892/ijmm.2015.2209
PMID:25976847
Abstract

Pulmonary hypertension (PH) develops in 30-70% of chronic obstructive pulmonary disease patients and increases morbidity and mortality. The present study aimed to investigate the regulation of small ubiquitin‑related modifier‑1 (SUMO‑1) expression in response to hypoxia. The experiments were carried out in vitro in rat pulmonary arterial smooth muscle cells (PASMCs) and in vivo using a rat hypoxic PH (HPH) model. A significant increase in SUMO‑1 mRNA and protein levels was observed following hypoxic stimulation in vivo and in vitro. SUMO‑1 is known to interact with various transcription factors, including hypoxia‑inducible factor‑1α (HIF‑1α) in vitro. Notably, the expression of HIF‑1α and its target gene, vascular endothelial growth factor, was increased by hypoxia in HPH. In addition, the present data suggest that SUMO‑1 regulated HIF‑1α in response to hypoxia (gene silencing and overexpression). Finally, the co‑immunoprecipitation assays suggest a direct and specific interaction between SUMO‑1 and HIF‑1α. In conclusion, SUMO‑1 may participate in the modulation of HIF‑1α through sumoylation in HPH. However, further studies are required to confirm this.

摘要

肺高血压(PH)在 30-70%的慢性阻塞性肺疾病患者中发展,并增加发病率和死亡率。本研究旨在研究小泛素相关修饰物-1(SUMO-1)表达对缺氧的调节。该实验在体外大鼠肺动脉平滑肌细胞(PASMCs)和体内大鼠低氧性 PH(HPH)模型中进行。在体内和体外缺氧刺激后,观察到 SUMO-1 mRNA 和蛋白水平显著增加。SUMO-1 已知与各种转录因子相互作用,包括体外缺氧诱导因子-1α(HIF-1α)。值得注意的是,HIF-1α及其靶基因血管内皮生长因子的表达在 HPH 中因缺氧而增加。此外,本数据表明 SUMO-1 通过基因沉默和过表达来调节缺氧反应中的 HIF-1α。最后,共免疫沉淀实验表明 SUMO-1 和 HIF-1α之间存在直接和特异性相互作用。总之,SUMO-1 可能通过 HPH 中的 SUMO 化参与 HIF-1α的调节。然而,需要进一步的研究来证实这一点。

相似文献

1
Increased SUMO-1 expression in response to hypoxia: Interaction with HIF-1α in hypoxic pulmonary hypertension.缺氧反应中 SUMO-1 表达增加:与低氧性肺动脉高压中的 HIF-1α 相互作用。
Int J Mol Med. 2015 Jul;36(1):271-81. doi: 10.3892/ijmm.2015.2209. Epub 2015 May 14.
2
[Effects of RNAi on hypoxia inducible factor-1alpha activity and proliferation of hypoxic pulmonary artery smooth muscle cells in rat].RNA干扰对大鼠缺氧性肺动脉平滑肌细胞缺氧诱导因子-1α活性及增殖的影响
Sheng Li Xue Bao. 2006 Feb 25;58(1):71-6.
3
SENP‑1 enhances hypoxia‑induced proliferation of rat pulmonary artery smooth muscle cells by regulating hypoxia‑inducible factor‑1α.SENP-1通过调节缺氧诱导因子-1α增强缺氧诱导的大鼠肺动脉平滑肌细胞增殖。
Mol Med Rep. 2016 Apr;13(4):3482-90. doi: 10.3892/mmr.2016.4969. Epub 2016 Mar 3.
4
Astragaloside IV improves angiogenesis under hypoxic conditions by enhancing hypoxia‑inducible factor‑1α SUMOylation.黄芪甲苷通过增强缺氧诱导因子-1α的 SUMO 化作用改善缺氧条件下的血管生成。
Mol Med Rep. 2021 Apr;23(4). doi: 10.3892/mmr.2021.11883. Epub 2021 Feb 4.
5
Expression and role of factor inhibiting hypoxia-inducible factor-1 in pulmonary arteries of rat with hypoxia-induced hypertension.缺氧诱导高血压大鼠肺动脉中缺氧诱导因子-1抑制因子的表达及作用
Acta Biochim Biophys Sin (Shanghai). 2008 Oct;40(10):883-92.
6
[Association between pulmonary vascular remodeling and expression of hypoxia-inducible factor-1α, endothelin-1 and inducible nitric oxide synthase in pulmonary vessels in neonatal rats with hypoxic pulmonary hypertension].[新生大鼠缺氧性肺动脉高压肺血管重构与肺血管中缺氧诱导因子-1α、内皮素-1及诱导型一氧化氮合酶表达的关系]
Zhongguo Dang Dai Er Ke Za Zhi. 2013 Feb;15(2):138-44.
7
HIF-1 alpha-induced up-regulation of miR-9 contributes to phenotypic modulation in pulmonary artery smooth muscle cells during hypoxia.低氧诱导因子-1α诱导的 miR-9 上调促进肺动脉平滑肌细胞在低氧时的表型调节。
J Cell Physiol. 2014 Oct;229(10):1511-20. doi: 10.1002/jcp.24593.
8
SUMOylation of Vps34 by SUMO1 promotes phenotypic switching of vascular smooth muscle cells by activating autophagy in pulmonary arterial hypertension.SUMO1 对 Vps34 的 SUMOylation 通过激活自噬促进肺动脉高压中血管平滑肌细胞的表型转换。
Pulm Pharmacol Ther. 2019 Apr;55:38-49. doi: 10.1016/j.pupt.2019.01.007. Epub 2019 Jan 28.
9
Increase of SUMO-1 expression in response to hypoxia: direct interaction with HIF-1alpha in adult mouse brain and heart in vivo.缺氧反应中SUMO-1表达的增加:在成年小鼠脑和心脏中与HIF-1α的直接体内相互作用。
FEBS Lett. 2004 Jul 2;569(1-3):293-300. doi: 10.1016/j.febslet.2004.05.079.
10
[Effect of opening of mitochondrial ATP-sensitive K(+) channels on the expression of hypoxia inducible factor-1alpha and cell proliferation in pulmonary arterial smooth muscle cells of rats].[线粒体ATP敏感性钾通道开放对大鼠肺动脉平滑肌细胞缺氧诱导因子-1α表达及细胞增殖的影响]
Sheng Li Xue Bao. 2007 Apr 25;59(2):157-62.

引用本文的文献

1
Biomarkers in COPD-Associated PH/CCP: Circulating Molecules and Cell-Intrinsic Marker.慢性阻塞性肺疾病相关肺动脉高压/慢性血栓栓塞性肺动脉高压中的生物标志物:循环分子和细胞固有标志物
Int J Chron Obstruct Pulmon Dis. 2025 Aug 15;20:2869-2883. doi: 10.2147/COPD.S521659. eCollection 2025.
2
Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies.肺动脉高压:分子机制与临床研究
MedComm (2020). 2025 Mar 10;6(3):e70134. doi: 10.1002/mco2.70134. eCollection 2025 Mar.
3
LncRNA H19 Promotes Angiogenesis in Mouse Pulmonary Artery Endothelial Cells by Regulating the HIF-1α/VEGF Signaling Pathway.
长链非编码RNA H19通过调控HIF-1α/VEGF信号通路促进小鼠肺动脉内皮细胞血管生成。
Biochem Genet. 2024 Dec 4. doi: 10.1007/s10528-024-10983-3.
4
DNA methylation in peripheral blood is associated with renal aging and renal function decline: a national community study.外周血 DNA 甲基化与肾脏衰老和肾功能下降相关:一项全国社区研究。
Clin Epigenetics. 2024 Jun 15;16(1):80. doi: 10.1186/s13148-024-01694-y.
5
G6PD is a prognostic biomarker correlated with immune infiltrates in lung adenocarcinoma and pulmonary arterial hypertension.葡萄糖-6-磷酸脱氢酶(G6PD)是一种与肺腺癌和肺动脉高压中的免疫浸润相关的预后生物标志物。
Aging (Albany NY). 2024 Jan 8;16(1):466-492. doi: 10.18632/aging.205381.
6
HSP70 via HIF-1 α SUMOylation inhibits ferroptosis inducing lung cancer recurrence after insufficient radiofrequency ablation.HSP70 通过 HIF-1α SUMOylation 抑制低剂量射频消融后诱导的肺癌复发的铁死亡。
PLoS One. 2023 Nov 10;18(11):e0294263. doi: 10.1371/journal.pone.0294263. eCollection 2023.
7
The emerging roles of SUMOylation in pulmonary diseases.SUMOylation 在肺部疾病中的新兴作用。
Mol Med. 2023 Sep 5;29(1):119. doi: 10.1186/s10020-023-00719-1.
8
Exploration of the molecular mechanism of tea polyphenols against pulmonary hypertension by integrative approach of network pharmacology, molecular docking, and experimental verification.采用网络药理学、分子对接和实验验证的综合方法探讨茶多酚防治肺动脉高压的分子机制。
Mol Divers. 2024 Aug;28(4):2603-2616. doi: 10.1007/s11030-023-10700-z. Epub 2023 Jul 24.
9
The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications.SUMO化修饰在肿瘤微环境中的新作用及治疗意义。
Exp Hematol Oncol. 2023 Jul 6;12(1):58. doi: 10.1186/s40164-023-00420-3.
10
Modulation of Ca1.2 Channel Function by Interacting Proteins and Post-Translational Modifications: Implications in Cardiovascular Diseases and COVID-19.相互作用蛋白和翻译后修饰对 Ca1.2 通道功能的调节:在心血管疾病和 COVID-19 中的意义。
Handb Exp Pharmacol. 2023;279:83-103. doi: 10.1007/164_2023_636.